OVERACTIVE BLADDER SYNDROME: IS A REQUEST FOR A DOSE INCREASE INDICATIVE OF MORE SEVERE SYMPTOMS? RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, RISFNG-DOSE STUDY OF SOLIFENACIN (SUNRISE) Article Cardozo L., Avdoshin V., Wolski Z., Pavlik I., Sofras F.E., Toth Z., Vasco P.M., Drogendijk T., Wright D.M., Bolodeoku J. INTERNATIONAL UROGYNECOLOGY JOURNAL. SPRINGER LONDON LTD. Vol. 18. 2007.
PREDICTORS OF REGRESSION AND PERSISTENCE LEFT VENTRICULAR HYPERTROPHY DURING LONG TERM ANTIHYPERTENSIVE TREATMENT Article Efimova V., Bulkina O., Malaya I., Milto A. Journal of Hypertension. Vol. 25. 2007.